No Data
No Data
Prime Drink Group to Oppose Lenders' Move to Appoint a Receiver for Its Triani Canada Unit
Cantor Analysts Call for RFK Jr. Replacement Following Ousting of Marks at FDA
How Peter Marks' FDA Departure Is Impacting Pharma, Biotech Stocks
Prime Medicine Is Maintained at Buy by Chardan Capital
Prime Medicine Price Target Raised to $16 From $15 at Chardan
Why Prime Medicine Stock Is Soaring Today
Saywallahcuzzy : any specific reason?
NVDAvsTSLA OP Saywallahcuzzy : Such a large amount of capital should indicate that Institutions have entered the market to open or increase their positions.